Featured Image
Why is it important?
High tumor burden and high tumor growth may be a poor prognostic factor for the patients treated with nivolumab.
Read the Original
This page is a summary of: Effect of tumor burden and growth rate on treatment outcomes of nivolumab in head and neck cancer, International Journal of Clinical Oncology, April 2020, Springer Science + Business Media,
DOI: 10.1007/s10147-020-01669-y.
You can read the full text:
Contributors
The following have contributed to this page
